Skip to main content

Align Technology, Inc.

corporate_fare Company Profile

Align Technology, Inc.

ALGN·NASDAQ·Industrial Applications And Services·CIK 0001097149

Align Technology, Inc. is a global medical device company that designs, manufactures, and markets products for orthodontic and restorative dentistry. The company's primary products include Invisalign® clear aligners, used by orthodontists and general dental practitioners (GPs) to treat misaligned teeth. Align also offers Vivera™ retainers for post-treatment retention, iTero™ intraoral scanners and related services for dentistry, and exocad™ computer-aided design and manufacturing (CAD/CAM) software for dental laboratories and practitioners. Align's strategy centers on its Align™ Digital Platform, an integrated suite of technologies and services aimed at providing digital treatment planning and implementation. The company's objectives include establishing Invisalign as a leading solution for malocclusion treatment globally, making iTero intraoral scanners the preferred technology for digital dental scans, and positioning exocad CAD/CAM software as a top choice for dental restorative solutions in labs. The company operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services ("Systems and Services"). For the year ended December 31, 2025, the Clear Aligner segment generated approximately 80% of worldwide net revenues, with Systems and Services accounting for the remaining 20%. Align sells most of its products and services directly to customers, including orthodontists, GPs (such as prosthodontists, periodontists, and oral surgeons), and dental laboratories, through a specialized sales force. Align's corporate headquarters are in Tempe, Arizona, with regional headquarters in Raleigh, North Carolina (Americas), Rotkreuz, Switzerland (EMEA), and Singapore (APAC).

Align Technology, Inc. (NASDAQ:ALGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for ALGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for ALGN spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Align Signs $270M Accelerated Buyback With Goldman Sachs, Completing $500M 2026 Program
  • Align 10-Q: Q3 EPS $1.90, Gross Margin 68.7%, $43.1M UK VAT Charge Booked
  • Align Q3'26 Revenue $1.01B, EPS $1.90; Q4 Guide $1.00-1.02B
  • Align Names P&G Healthcare Chief Jennifer Davis CEO, Replacing Joe Hogan on December 31
  • Paris Court Backs Align in Patent Fight, Orders Rival to Pull Torque Ridges in Europe

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.03B
Net Income
$410.35M
Diluted EPS
$5.65
Op. Cash Flow
$593.22M
Free Cash Flow
$490.78M
Gross Profit
$2.71B
Operating Income
$545.75M
Cash & Equivalents
$1.09B
Debt / Equity
0.00×
Net Margin
10.2%
Shares Outstanding
71.36M sh
Source: 10-K · filed 2026-02-27 · accession 0001097149-26-000014

Short Interest & Short Volume

3.95 days to cover

FINRA reported short interest of 4,109,362 shares in ALGN as of the October 30, 2026 settlement, a 0.9% decrease from the prior period — about 4.0 days to cover at its recent average daily volume. On November 20, 2026, 56.1% of ALGN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,109,362 shares as of October 30, 2026
Change vs prior period▼ 0.9%
Days to cover3.95 at avg daily volume of 1,040,653
Daily short volume (FINRA facilities)56.1% of 496,375 shares on November 20, 2026
5-day average short volume65.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$155.17
52-week range · as of 2026-11-06 $130.23 – $200.44
Market cap
$10.94B
Volume
1.3M (1.2× avg)
3-mo avg 1.1M
Live data · 2026-11-21 14:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ALGN - Latest Insights

ALGN
Nov 05, 2026, 9:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $159.37
Real-time Price: $155.17 info
Change: -$4.20 (-3%) info
Market Cap: $10.937B info
ALGN
Nov 04, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $164.90
Real-time Price: $155.17 info
Change: -$9.73 (-6%) info
Market Cap: $10.937B info
ALGN
Oct 28, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Updated Oct 28, 4:07 PM ET — Align Technology reported Q3'26 revenue of $1,014.8M, up 1.9% YoY, and non-GAAP diluted EPS of $2.80.
Price at Filing: $153.62
Real-time Price: $155.17 info
Change: +$1.55 (+1%) info
Market Cap: $10.937B info
ALGN
Oct 28, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Updated Oct 28, 4:06 PM ET — Davis joins as CEO-elect and director on November 2, 2026, and Hogan retires from the Board after its June 16, 2027 strategy meeting.
Price at Filing: $153.62
Real-time Price: $155.17 info
Change: +$1.55 (+1%) info
Market Cap: $10.937B info
ALGN
Oct 16, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $148.20
Real-time Price: $155.17 info
Change: +$6.97 (+5%) info
Market Cap: $10.937B info
ALGN
Oct 05, 2026, 4:22 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $140.65
Real-time Price: $155.17 info
Change: +$14.52 (+10%) info
Market Cap: $10.937B info
ALGN
Jul 29, 2026, 6:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $169.99
Real-time Price: $155.17 info
Change: -$14.82 (-9%) info
Market Cap: $10.937B info
ALGN
Jul 29, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $171.00
Real-time Price: $155.17 info
Change: -$15.83 (-9%) info
Market Cap: $10.937B info
ALGN
Jul 29, 2026, 4:24 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $173.00
Real-time Price: $155.17 info
Change: -$17.83 (-10%) info
Market Cap: $10.937B info
ALGN
Jul 29, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $167.00
Real-time Price: $155.17 info
Change: -$11.83 (-7%) info
Market Cap: $10.937B info
ALGN
Jul 29, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $169.00
Real-time Price: $155.17 info
Change: -$13.83 (-8%) info
Market Cap: $10.937B info
ALGN
Jul 08, 2026, 8:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $174.48
Real-time Price: $155.17 info
Change: -$19.31 (-11%) info
Market Cap: $10.937B info
ALGN
Jun 30, 2026, 9:25 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $168.00
Real-time Price: $155.17 info
Change: -$12.83 (-8%) info
Market Cap: $10.937B info
ALGN
Jun 18, 2026, 9:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $178.44
Real-time Price: $155.17 info
Change: -$23.27 (-13%) info
Market Cap: $10.937B info
ALGN
May 06, 2026, 4:43 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $173.94
Real-time Price: $155.17 info
Change: -$18.77 (-11%) info
Market Cap: $10.937B info
ALGN
Apr 29, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $187.60
Real-time Price: $155.17 info
Change: -$32.43 (-17%) info
Market Cap: $10.937B info
ALGN
Feb 27, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $190.10
Real-time Price: $155.17 info
Change: -$34.93 (-18%) info
Market Cap: $10.937B info
ALGN
Feb 04, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $167.32
Real-time Price: $155.17 info
Change: -$12.15 (-7%) info
Market Cap: $10.937B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets